参考文献/References:
[1] CHARALAMPAKIS N,ECONOMOPOULOU P,KOTSANTIS I,et al.Medical management of gastric cancer:a 2017 update[J].Cancer Med,2018,7(1):123-133.
[2] 吴朝旭,王玥,李潇,等.基于80例晚期胃癌患者的临床资料构建晚期胃癌人群类别预测的判别模型[J].世界中医药,2021,16(3):393-396.
WU C X,WANG Y,LI X,et al.Establishment of a discriminant model for predicting the classification of advanced gastric cancer,based on the clinical data of 80 patients with advanced gastric cancer[J].World Chin Med,2021,16(3):393-396.
[3] BRAY F,FERLAY J,SOERJOMATARAM I,et al.Global cancer statistics 2018:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin,2018,68(6):394-424.
[4] GALE D P,OYGAR D D,LIN F,et al.A novel COL4A1 frameshift mutation in familial kidney disease:the importance of the C-terminal NC1 domain of type IV collagen[J].Nephrol Dial Transplant,2016,31(11):1908-1914.
[5] MARION J,JEFF J,GOULD D B.Molecular and genetic analyses of collagen type IV mutant mouse models of spontaneous intracerebral hemorrhage identify mechanisms for stroke prevention[J].Circulation,2015,131(18):1555-1565.
[6] MIYAKE M,MORIZAWA Y,HORI S,et al.Diagnostic and prognostic role of urinary collagens in primary human bladder cancer[J].Cancer Sci,2017,108(11):2221-2228.
[7] MIYAKE M,HORI S,MORIZAWA Y,et al.Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder[J].Oncotarget,2017,8(22):36099-36114.
[8] JIN R,JIA S,ZHANG T,et al.The highly expressed COL4A1 genes contributes to the proliferation and migration of the invasive ductal carcinomas[J].Oncotarget,2017,8(35):58172-58183.
[9] LI D F,WANG N N,CHANG X,et al.Bioinformatics analysis suggests that COL4A1 may play an important role in gastric carcinoma recurrence[J].J Dig Dis,2019,20(8):391.
[10] PLAISIER E,GRIBOUVAL O,ALAMOWITCH S,et al.COL4A1 mutations and hereditary angiopathy,nephropathy,aneurysms,and muscle cramps[J].N Engl J Med,2007,357(26):2687-2695.
[11] RAGHU K.Basement membranes:structure,assembly and role in tumour angiogenesis[J].Nat Rev Cancer,2003,3(6):422-433.
[12] DONNELL C J,MARYAM K,SMITH A V,et al.Genome-wide association study for coronary artery calcification with follow-up in myocardial infarction[J].Circulation,2011,124(25):2855-2864.
[13] DESERT R,MEBARKI S,DESILLE M,et al.“Fibrous nests” in human hepatocellular carcinoma express a Wnt-induced gene signature associated with poor clinical outcome[J].Int J Biochem Cell Biol,2016,81(Pt A):195-207.
[14] SALEM O,ERDEM N,JUNG J,et al.The highly expressed 5′isomiR of hsa-miR-140-3p contributes to the tumor-suppressive effects of miR-140 by reducing breast cancer proliferation and migration[J].BMC Genomics,2016,17(1):566.
[15] HUANG R,GU W,SUN B,et al.Identification of COL4A1 as a potential gene conferring trastuzumab resistance in gastric cancer based on bioinformatics analysis[J].Mol Med Rep,2018,17(5):6387-6396.
[16] LING C,YAN C,MIAO Z,et al.Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis[J].Peer J,2018,6:e5180.
[17] YE B,JIANG L,XU H,et al.Expression and PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis[J].Int J Immunopathol Pharmacol,2012,25(3):627-636.
[18] HU M,LI F,WANG W.Vitexin protects dopaminergic neurons in MPTP-induced Parkinson′s disease through PI3K/Akt signaling pathway[J].Drug Des Devel Ther,2018,12:565-573.
[19] ZHANG Z,YU W,ZHENG M,et al.Pin1 inhibition potently suppresses gastric cancer growth and blocks PI3K/AKT and Wnt/β-catenin oncogenic pathways[J].Mol Carcinog,2019,58(8):1450-1464.
[20] 杨立霞,王楠,刘洋.PI3K/Akt信号通路调节心脏功能的研究进展[J].心脏杂志,2018,30(3):344-347.
YANG L X,WANG N,LIU Y.Research progress of PI3K/Akt signaling pathway in regulating cardiac functions[J].Chin Heart J,2018,30(3):344-347.
[21] HUANG Y K,KANG W M,MA Z Q,et al.NUCKS1 promotes gastric cancer cell aggressiveness by upregulating IGF-1R and subsequently activating the PI3K/Akt/mTOR signaling pathway[J].Carcinogenesis,2019,40(2):370-379.
[22] YANG Z P,ZHAO Y,HUANG F,et al.Equol inhibits proliferation of human gastric carcinoma cells via modulating Akt pathway[J].World J Gastroenterol,2015,21(36):10385-10399.
[23] RYU D,LEE C.Expression quantitative trait loci for PI3K/AKT pathway[J].Medicine,2017,96(1):e5817.
相似文献/References:
[1]陈赜,陈杰,严想元,等.腹腔镜辅助胃癌根治术治疗早期胃癌疗效观察[J].新乡医学院学报,,():000.
[2]于成功,萧树东,赵宪邨,等.胃癌胃良性病变患者血清和局部组织中IL—I水平及意义[J].新乡医学院学报,1996,13(03):220.
[3]王淑秀,赵卫星,和瑞芝,等.P~(53)和rasP~(21)在胃癌中表达的免疫组化研究[J].新乡医学院学报,1997,14(02):137.
[4]赵卫星,王淑秀,卢朝晖,等.幽门螺杆菌与胃癌基因抑癌基因突变的关系[J].新乡医学院学报,1997,14(03):203.
[5]王淑秀.抑癌基因和癌基因与胃癌[J].新乡医学院学报,1997,14(01):083.
[6]冯艳玲,乐晓萍,蔡新华.胃癌患者P16和P53蛋白的表达及其相互关系[J].新乡医学院学报,2000,17(06):403.
[7]周玲生.纤维胃镜粘膜活检1356 例病理分析[J].新乡医学院学报,2000,17(06):462.
[8]任金萍,王淑秀,付华民,等.青年与老年人胃癌中PCNA和AgNOR计数表达的对比研究[J].新乡医学院学报,2000,17(03):156.
[9]贾文英,张合喜,马彦民.幽门螺杆菌感染与胃癌关系的Meta 分析[J].新乡医学院学报,2000,17(05):328.
[10]窦天伟,刘 炯,罗志勇,等.复发胃癌再次手术42例疗效和随访结果[J].新乡医学院学报,2003,20(05):337.